Literature DB >> 25257465

A new HCV mouse model on the block.

Rajiv G Tawar1, Laurent Mailly1, Thomas F Baumert2.   

Abstract

The investigation of virus-induced liver disease and hepatocellular carcinoma needs small animal models modeling hepatitis C virus (HCV) infection and liver disease biology. A recent study published in Cell Research reports a novel mouse model which is permissive for chronic HCV infection and shows chronic liver injury including inflammation, steatosis and fibrosis.

Entities:  

Mesh：

Year:  2014        PMID： 25257465      PMCID： PMC4185350          DOI： 10.1038/cr.2014.126

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


  9 in total

1.  Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment.

Authors:  Karl-Dimiter Bissig; Stefan F Wieland; Phu Tran; Masanori Isogawa; Tam T Le; Francis V Chisari; Inder M Verma
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

2.  Curing chronic hepatitis C--the arc of a medical triumph.

Authors:  Raymond T Chung; Thomas F Baumert
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

3.  Hepatitis C virus replication in mice with chimeric human livers.

Authors:  D F Mercer; D E Schiller; J F Elliott; D N Douglas; C Hao; A Rinfret; W R Addison; K P Fischer; T A Churchill; J R Lakey; D L Tyrrell; N M Kneteman
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

4.  A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease.

Authors:  Michael L Washburn; Moses T Bility; Liguo Zhang; Grigoriy I Kovalev; Adam Buntzman; Jeffery A Frelinger; Walter Barry; Alexander Ploss; Charles M Rice; Lishan Su
Journal:  Gastroenterology       Date:  2011-01-13       Impact factor: 22.682

5.  A genetically humanized mouse model for hepatitis C virus infection.

Authors:  Marcus Dorner; Joshua A Horwitz; Justin B Robbins; Walter T Barry; Qian Feng; Kathy Mu; Christopher T Jones; John W Schoggins; Maria Teresa Catanese; Dennis R Burton; Mansun Law; Charles M Rice; Alexander Ploss
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

6.  Completion of the entire hepatitis C virus life cycle in genetically humanized mice.

Authors:  Marcus Dorner; Joshua A Horwitz; Bridget M Donovan; Rachael N Labitt; William C Budell; Tamar Friling; Alexander Vogt; Maria Teresa Catanese; Takashi Satoh; Taro Kawai; Shizuo Akira; Mansun Law; Charles M Rice; Alexander Ploss
Journal:  Nature       Date:  2013-07-31       Impact factor: 49.962

7.  Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice.

Authors:  Jizheng Chen; Yang Zhao; Chao Zhang; Hairong Chen; Jin Feng; Xiumei Chi; Yu Pan; Jun Du; Min Guo; Huang Cao; Honghe Chen; Zilong Wang; Rongjuan Pei; Qian Wang; Lei Pan; Junqi Niu; Xinwen Chen; Hong Tang
Journal:  Cell Res       Date:  2014-08-26       Impact factor: 25.617

Review 8.  Barriers of hepatitis C virus interspecies transmission.

Authors:  Lisa Sandmann; Alexander Ploss
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

9.  Hepatitis C virus infection and related liver disease: the quest for the best animal model.

Authors:  Laurent Mailly; Eric Robinet; Philip Meuleman; Thomas F Baumert; Mirjam B Zeisel
Journal:  Front Microbiol       Date:  2013-07-26       Impact factor: 5.640
  9 in total
  1 in total

Review 1.  Cardiovascular inflammation: RNA takes the lead.

Authors:  Colton R Martens; Shyam S Bansal; Federica Accornero
Journal:  J Mol Cell Cardiol       Date:  2019-03-14       Impact factor: 5.000
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.